Hepatitis B virus (HBV) is a main cause of chronic and acute hepatitis. Healthcare workers (HCWs), including medical students and resident doctors, have an occupational risk of HBV infection.
The study aimed to evaluate the long-term persistence of protective anti-HBs antibody levels in healthcare students and resident doctors at risk for occupational exposure to (HBV) at 15 years after primary vaccination course. Further objective was to evaluate the anamnestic response observed in non-seroprotected subjects receiving a booster dose.
Data were collected from the clinical documentation filled in during the occupational medical check of medical students and resident doctors undergoing Occupational Health Surveillance by the University of Ferrara.
Of the 621 included individuals, 27.7% had an anti-HBs concentration <10 mIU/mL. Subjects vaccinated during infancy had more frequently a concentration <10mIU/mL than those vaccinated during adolescence (42.7% versus 6.9%; p-value <0.001). Multivariate analysis confirmed the statistical significance of the vaccination age. 94 subjects who had an anti-HBs concentration <10 mIU/mL received a booster dose. The proportion of subjects who had an anamnestic response was higher in those vaccinated in infancy rather than during adolescence (94.1% versus 77.8% respectively).
These findings suggest that the anti-HBs concentration decreases below 10 mIU/mL more frequently in subjects vaccinated during infancy. Immunological memory seems to persist after the decline of the anti-HB titer, as observed in response to a booster dose. In conclusion, vaccinated subjects at increased risk of HBV infection should be monitored and a booster dose administered if anti-HBs titer is below 10 mIU/mL.
Romanò L, Galli C, Tagliacarne C, Tosti ME, Velati C, Fomiatti L, Chironna M, Coppola RC, Cuccia M, Mangione R, Marrone F, Negrone FS, Parlato A, Zotti CM, Mele A, Zanetti AR; Study Group. Persistence of immunity 18-19 years after vaccination against hepatitis B in 2 cohorts of vaccinees primed as infants or as adolescents in Italy. Hum Vaccin Immunother. 2017;13(5):981-985. doi: 10.1080/21645515.2017.1264795.
World Health Organization (WHO), Hepatitis B, WHO, 2017. Available at: http://www.who.int/mediacentre/factsheets/fs204/en/. Accessed on: 10/06/2019.
Zanetti AR, Mariano A, Romanò L, D'Amelio R, Chironna M, Coppola RC, Cuccia M, Mangione R, Marrone F, Negrone FS, Parlato A, Zamparo E, Zotti C, Stroffolini T, Mele A; Study Group. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study. Lancet. 2005 Oct 15-21;366(9494):1379-84. doi: 10.1016/S0140-6736(05)67568-X.
European Centre for Disease Prevention and Control (ECDC) Surveillance Report. Annual Epidemiological Report for 2015 Hepatitis B. 2017. Available at: https://ecdc.europa.eu/en/publications-data/hepatitis-b-annual-epidemiological-report-2015-0. Accessed on 10/06/2019.
Mele A, Stroffolini T, Zanetti AR. Hepatitis B in Italy: where we are ten years after the introduction of mass vaccination. J Med Virol. 2002;67(3):440-3. doi: 10.1002/jmv.10092.
Stroffolini T, Mele A, Tosti ME, Gallo G, Balocchini E, Ragni P, Santonastasi F, Marzolini A, Ciccozzi M, Moiraghi A. The impact of the hepatitis B mass immunisation campaign on the incidence and risk factors of acute hepatitis B in Italy. J Hepatol. 2000;33(6):980-5.
Zanetti AR. Update on hepatitis B vaccination in Italy 10 years after its implementation. Vaccine;19(17-19):2380-3.
Chen DS. Hepatitis B vaccination: The key towards elimination and eradication of hepatitis B. J Hepatol. 2009;50(4):805-16. doi: 10.1016/j.jhep.2009.01.002.
Italian Minister of Health; Italian National Vaccine Prevention Plan 2017-2019 Available at: http://www.salute.gov.it/imgs/C_17_pubblicazioni_2571_allegato.pdf. Italian. Accessed on 10/06/2019.
Romanò L, Galli C, Tagliacarne C, Zanetti AR. Lessons learnt over two decades of vaccination against hepatitis B in Italy. J Prev Med Hyg. 2015;56(1):E12-4
West DJ. Clinical experience with hepatitis B vaccines. Am J Infect Control. 1989;17(3):172-80.
Leuridan E, Van Damme P. Hepatitis B and the need for a booster dose. Clin Infect Dis. 2011;53(1):68-75. doi: 10.1093/cid/cir270.
van der Sande MA, Waight PA, Mendy M, Zaman S, Kaye S, Sam O, Kahn A, Jeffries D, Akum AA, Hall AJ, Bah E, McConkey SJ, Hainaut P, Whittle HC. Long-term protection against HBV chronic carriage of Gambian adolescents vaccinated in infancy and immune response in HBV booster trial in adolescence. PLoS One. 2007 Aug 15;2(8):e753. doi: 10.1371/journal.pone.0000753.
Banatvala J, Van Damme P, Oehen S. Lifelong protection against hepatitis B: the role of vaccine immunogenicity in immune memory. Vaccine. 2000 Nov 22;19(7-8):877-85. doi:10.1016/S0264-410X(00)00224-3
Banatvala JE, Van Damme P. Hepatitis B vaccine -- do we need boosters? J Viral Hepat. 2003;10(1):1-6. doi: 10.1046/j.1365-2893.2003.00400.x.
European Consensus Group on Hepatitis B Immunity. Are booster immunisations needed for lifelong hepatitis B immunity? Lancet. 2000;355(9203):561-5. doi: 10.1016/S0140-6736(99)07239-6.
West DJ, Calandra GB. Vaccine induced immunologic memory for hepatitis B surface antigen: implications for policy on booster vaccination. Vaccine. 1996;14(11):1019-27. doi: 10.1016/0264-410X(96)00062-X.
Legislative Decree no. 81, April 9th 2008. Comprehensive Law on health and safety at work (and subsequent amendments and additions). Gazzetta Ufficiale della Repubblica Italiana n. 101, 30 april 2008. Italian.
Ministerial Decree, November 20th 2000. Update of the protocol for vaccination against viral hepatitis B. Gazzetta Ufficiale della Repubblica Italiana 2000. Italian
Regulation no. 351 of Emilia-Romagna Region of 12 March 2018 on Biological Risk in Health Environment. Available at: http://servizissiir.regione.emilia-romagna.it/deliberegiunta/servlet/AdapterHTTP?action_name=ACTIONRICERCADELIBERE&operation=leggi&cod_protocollo=GPG/2018/376&ENTE=1. Italian. Accessed on 10/06/2019.
Legislative Decree no. 165 May 27th 1991 on mandatory vaccination against viral hepatitis B. Gazzetta Ufficiale della Repubblica Italiana 1991. Italian.
World Health Organization (WHO), Hepatitis B vaccines: WHO position paper. Wkly Epidemiol Rec. 2009 84 (40): 405–420.
Regulation of the Italian Minister of Health of 20 November 2000 on scheme of beahavior for vaccination against viral hepatitis B. Circolare no. 19, 2000. Italian.
Dini G, Toletone A, Barberis I, Debarbieri N, Massa E, Paganino C, Bersi F, Montecucco A, Alicino C, Durando P. Persistence of protective anti-HBs antibody levels and anamnestic response to HBV booster vaccination: A cross-sectional study among healthcare students 20 years following the universal immunization campaign in Italy. Hum Vaccin Immunother. 2017;13(2):440-444. doi: 10.1080/21645515.2017.1264788.
Bini C, Grazzini M, Chellini M, Mucci N, Arcangeli G, Tiscione E, Bonanni P. Is hepatitis B vaccination performed at infant and adolescent age able to provide long-term immunological memory? An observational study on healthcare students and workers in Florence, Italy. Hum Vaccin Immunother. 2018;14(2):450-455. doi: 10.1080/21645515.2017.1398297
Jan CF, Huang KC, Chien YC, Greydanus DE, Davies HD, Chiu TY, Huang LM, Chen CJ, Chen DS. Determination of immune memory to hepatitis B vaccination through early booster response in college students. Hepatology. 2010;51(5):1547-54. doi: 10.1002/hep.23543.
Pileggi C, Papadopoli R, Bianco A, Pavia M. Hepatitis B vaccine and the need for a booster dose after primary vaccination. Vaccine. 2017;35(46):6302-6307. doi: 10.1016/j.vaccine.2017.09.076.
Ryckman KK, Fielding K, Hill AV, Mendy M, Rayco-Solon P, Sirugo G, van der Sande MA, Waight P, Whittle HC, Hall AJ, Williams SM, Hennig BJ. Host genetic factors and vaccine-induced immunity to HBV infection: haplotype analysis. PLoS One. 2010;5(8):e12273. doi: 10.1371/journal.pone.0012273.
Siegrist CA. Vaccination in the neonatal period and early infancy. Int Rev Immunol. 2000;19(2-3):195-219.
Dentinger CM, McMahon BJ, Butler JC, Dunaway CE, Zanis CL, Bulkow LR, Bruden DL, Nainan OV, Khristova ML, Hennessy TW, Parkinson AJ. Persistence of antibody to hepatitis B and protection from disease among Alaska natives immunized at birth. Pediatr Infect Dis J. 2005;24(9):786-92. doi: 10.1097/01.inf.0000176617.63457.9f.
Zhao H, Zhou YH. Revaccination against hepatitis B in late teenagers who received vaccination during infancy: Yes or no?. Hum Vaccin Immunother. 2018;14(2):456–463. doi:10.1080/21645515.2017.1397243.
Lamberti M, De Rosa A, Garzillo EM, Corvino AR, Sannolo N, De Pascalis S, Di Fiore E, Westermann C, Arnese A, Gabriella DG, Nienhaus A, Sobrinho APR, Coppola N. Vaccination against hepatitis b virus: are Italian medical students sufficiently protected after the public vaccination programme? J Occup Med Toxicol. 2015;10:41. doi: 10.1186/s12995-015-0083-4.
Coppeta L, Pompei A, Balbi O, et al. Persistence of Immunity for Hepatitis B Virus among Heathcare Workers and Italian Medical Students 20 Years after Vaccination. Int J Environ Res Public Health. 2019;16(9):1515. doi:10.3390/ijerph16091515
Betsch C, Wicker S. Personal attitudes and misconceptions, not official recommendations guide occupational physicians' vaccination decisions. Vaccine. 2014;32(35):4478-84. doi: 10.1016/j.vaccine.2014.06.046.
Riccò M, Cattani S, Casagranda F, Gualerzi G, Signorelli C. Knowledge, attitudes, beliefs and practices of occupational physicians towards vaccinations of health care workers: A cross sectional pilot study in North-Eastern Italy. Int J Occup Med Environ Health. 2017;30(5):775-790. doi: 10.13075/ijomeh.1896.00895.
Rosenberg C, Bovin NV, Bram LV, Flyvbjerg E, Erlandsen M, Vorup-Jensen T, Petersen E. Age is an important determinant in humoral and T cell responses to immunization with hepatitis B surface antigen. Hum Vaccin Immunother. 2013;9(7):1466-76. doi: 10.4161/hv.24480.
Schillie S, Vellozzi C, Reingold A, Harris A, Haber P, Ward JW, Nelson NP. Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep. 2018;67(1):1-31. doi: 10.15585/mmwr.rr6701a1.